中国学者近期发表的论文
Health utility by Psoriasis Area and Severity Index response status after biologic induction therapy in Chinese patients with moderate to severe psoriasi
Journal: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2026; Vol. 15, Issue 4, pp. -. DOI: 10.57264/cer-2025-0122
Comparing the efficacy of cipaglucosidase alfa plus miglustat with alglucosidase alfa for late-onset Pompe disease: an expanded network meta-analysis utilizing patient-level and aggregate dat
Journal: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.57264/cer-2025-0174
Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in Chin
Journal: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.57264/cer-2025-0190
Lefamulin versus omadacycline for community acquired bacterial pneumonia: a systematic review and anchored indirect treatment comparison using moxifloxacin as the common comparato
Journal: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.57264/cer-2025-0188
Impact of lymph node dissection on overall survival and cancer-specific survival in elderly patients with early-stage non-small cell lung cancer: a SEER database analysi
Journal: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.57264/cer-2025-0038
A process to validate prognostic factors unanchored matching-adjusted indirect comparison of single-arm trials in oncology: a proof-of-concept stud
Journal: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2025; Vol. , Issue , pp. -. DOI: 10.57264/cer-2024-0235
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therap
Journal: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2025; Vol. , Issue , pp. -. DOI: 10.57264/cer-2024-0127
高引用文章
Real-world evidence for coverage decisions: opportunities and challenges
引用次数:9
Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database
引用次数:7
Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib
引用次数:6
A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions
引用次数:6
Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry
引用次数:5
Impact of selective serotonin reuptake inhibitors in the veteran population: 10-year risk outcomes
引用次数:4
Experience with developing antibiotic stewardship programs in Serbia: potential model for other Balkan countries?
引用次数:4
Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis
引用次数:4
Qualitative interviews to identify burden of illness, impacts and costs associated with surgical site infections
引用次数:3
Economic evaluation of trifluridine and tipiracil hydrochloride in the treatment of metastatic colorectal cancer in Greece
引用次数:3